25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

EKAD (Ekadharma) Stock Analysis
Buy, Hold or Sell?

Let's analyze Ekadharma together

I guess you are interested in Ekadharma International Tbk. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Ekadharma’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Ekadharma’s Price Targets

I'm going to help you getting a better view of Ekadharma International Tbk. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Ekadharma International Tbk

I send you an email if I find something interesting about Ekadharma International Tbk.

1. Quick Overview

1.1. Quick analysis of Ekadharma (30 sec.)










1.2. What can you expect buying and holding a share of Ekadharma? (30 sec.)

How much money do you get?

How much money do you get?
Rp58.78
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
Rp5,436,301.85
Expected worth in 1 year
Rp5,648,558.22
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
Rp800,045.48
Return On Investment
425,556.1%

For what price can you sell your share?

Current Price per Share
Rp188.00
Expected price per share
Rp180.00 - Rp192.00
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ekadharma (5 min.)




Live pricePrice per Share (EOD)
Rp188.00
Rp5,436,301.85

2.2. Growth of Ekadharma (5 min.)




Is Ekadharma growing?

Current yearPrevious yearGrowGrow %
How rich?$1.8t$1.8t$18.5b1.0%

How much money is Ekadharma making?

Current yearPrevious yearGrowGrow %
Making money$105.5b$117.8b-$12.3b-11.7%
Net Profit Margin12.1%13.9%--

How much money comes from the company's main activities?

2.3. Financial Health of Ekadharma (5 min.)




2.4. Comparing to competitors in the Specialty Chemicals industry (5 min.)




  Industry Rankings (Specialty Chemicals)  


Richest
#2 / 518

Most Revenue
#3 / 518

Most Profit
#2 / 518
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ekadharma?

Welcome investor! Ekadharma's management wants to use your money to grow the business. In return you get a share of Ekadharma.

First you should know what it really means to hold a share of Ekadharma. And how you can make/lose money.

Speculation

The Price per Share of Ekadharma is Rp188.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ekadharma.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ekadharma, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is Rp5,436,301.85. Based on the TTM, the Book Value Change Per Share is Rp53,064.09 per quarter. Based on the YOY, the Book Value Change Per Share is Rp163,769.74 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is Rp146,947.28 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ekadharma.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 Rp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per ShareRp% of Price per Share
Usd Eps30.2216.1%30.2216.1%33.7417.9%33.3217.7%38.5520.5%36.0019.1%
Usd Book Value Change Per Share5.312.8%5.312.8%16.388.7%20.1210.7%28.7515.3%41.8022.2%
Usd Dividend Per Share14.697.8%14.697.8%14.627.8%15.188.1%14.227.6%9.795.2%
Usd Total Gains Per Share20.0010.6%20.0010.6%30.9916.5%35.3018.8%42.9722.9%51.5927.4%
Usd Price Per Share0.02-0.02-0.02-0.02-0.07-0.07-
Price to Earnings Ratio0.00-0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio0.00-0.00-0.00-0.00-0.00-0.00-
Price to Book Ratio0.00-0.00-0.00-0.00-0.00-0.00-
Price-to-Total Gains Ratio0.00-0.00-0.00-0.00-0.00-0.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0188
Number of shares53191
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share14.6914.22
Usd Book Value Change Per Share5.3128.75
Usd Total Gains Per Share20.0042.97
Gains per Quarter (53191 shares)1,063,880.482,285,791.21
Gains per Year (53191 shares)4,255,521.929,143,164.86
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1312650911290134255512302536861177969143155
262530182258026851103460507371223559318286320
3937952733870391276655690761051835338927429485
412506036451605117022078121014742447118636572650
515632545564506421277600151268423058898245715815
618759054677407725533122181522113670677854858980
721885564790309029788644211775794282457564002145
825012073903210334044166242029484894237173145310
9281385821016111638299688272283165506016882288475
10312650911129012842555210302536846117796491431640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Ekadharma International Tbk compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--53064.09253064.0920%163769.744-68%201171.421-74%287539.077-82%417976.677-87%
Book Value Per Share--5436301.8495436301.8490%5383237.758+1%5346335.873+2%5067714.712+7%3999036.069+36%
Current Ratio--15.03015.0300%14.207+6%13.664+10%11.371+32%8.180+84%
Debt To Asset Ratio--0.1050.1050%0.080+31%0.091+15%0.103+2%0.136-23%
Debt To Equity Ratio--0.1170.1170%0.089+31%0.102+15%0.118-1%0.168-30%
Dividend Per Share--146947.279146947.2790%146168.554+1%151846.439-3%142193.625+3%97908.902+50%
Enterprise Value--5742056722624390.0005742056722624390.0000%6280279740342286.000-9%5766384200130428.0000%5042375144303739.000+14%2596533801153797.000+121%
Eps--302213.591302213.5910%337434.478-10%333161.562-9%385546.755-22%359950.792-16%
Ev To Sales Ratio--0.6610.6610%0.739-11%0.641+3%0.534+24%0.271+143%
Gross Profit Margin--1.0001.0000%0.992+1%0.996+0%0.996+0%0.993+1%
Market Cap656847575040.000-13%740701500000.000740701500000.0000%866481000000.000-15%861822500000.000-14%2414267625000.000-69%2468422698473.500-70%
Net Profit Margin--0.1210.1210%0.139-12%0.128-5%0.138-12%0.125-2%
Operating Margin----0%0.144-100%0.096-100%0.137-100%0.148-100%
Operating Ratio--0.6890.6890%0.856-19%0.800-14%0.801-14%0.823-16%
Pb Ratio0.000-13%0.0000.0000%0.000-15%0.000-16%0.000-73%0.000-80%
Pe Ratio0.001-13%0.0010.0010%0.001-5%0.001-5%0.002-56%0.002-63%
Price Per Share188.000-13%212.000212.0000%248.000-15%246.667-14%691.000-69%706.500-70%
Price To Free Cash Flow Ratio----0%0.001-100%0.000-100%0.003-100%0.004-100%
Price To Total Gains Ratio0.001-13%0.0010.0010%0.001+32%0.001+34%0.001-28%0.002-35%
Quick Ratio--19.02219.0220%18.043+5%15.536+22%11.915+60%7.466+155%
Return On Assets--0.0500.0500%0.058-14%0.057-12%0.069-28%0.085-41%
Return On Equity--0.0560.0560%0.065-14%0.064-13%0.079-30%0.103-46%
Total Gains Per Share--200011.370200011.3700%309938.299-35%353017.860-43%429732.702-53%515885.579-61%
Usd Book Value--1899375912351.7781899375912351.7780%1880835982012.280+1%1867942924938.107+2%1770596174064.024+7%1397213219038.449+36%
Usd Book Value Change Per Share--5.3065.3060%16.377-68%20.117-74%28.754-82%41.798-87%
Usd Book Value Per Share--543.630543.6300%538.324+1%534.634+2%506.771+7%399.904+36%
Usd Dividend Per Share--14.69514.6950%14.617+1%15.185-3%14.219+3%9.791+50%
Usd Enterprise Value--574205672262.439574205672262.4390%628027974034.229-9%576638420013.0430%504237514430.374+14%259653380115.380+121%
Usd Eps--30.22130.2210%33.743-10%33.316-9%38.555-22%35.995-16%
Usd Free Cash Flow----0%123144523150.786-100%88547319053.884-100%135686896868.193-100%110360800099.482-100%
Usd Market Cap65684757.504-13%74070150.00074070150.0000%86648100.000-15%86182250.000-14%241426762.500-69%246842269.847-70%
Usd Price Per Share0.019-13%0.0210.0210%0.025-15%0.025-14%0.069-69%0.071-70%
Usd Profit--105589651100.031105589651100.0310%117895388632.349-10%116402485115.630-9%134705216748.356-22%125762307957.703-16%
Usd Revenue--869218284616.388869218284616.3880%849434773868.267+2%908532105112.205-4%971646723842.107-11%1017031971845.704-15%
Usd Total Gains Per Share--20.00120.0010%30.994-35%35.302-43%42.973-53%51.589-61%
 EOD+3 -4MRQTTM+0 -0YOY+15 -203Y+13 -225Y+17 -1810Y+18 -17

3.3 Fundamental Score

Let's check the fundamental score of Ekadharma International Tbk based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-150.001
Price to Book Ratio (EOD)Between0-10.000
Net Profit Margin (MRQ)Greater than00.121
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than119.022
Current Ratio (MRQ)Greater than115.030
Debt to Asset Ratio (MRQ)Less than10.105
Debt to Equity Ratio (MRQ)Less than10.117
Return on Equity (MRQ)Greater than0.150.056
Return on Assets (MRQ)Greater than0.050.050
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Ekadharma International Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.106
Ma 20Greater thanMa 50188.300
Ma 50Greater thanMa 100185.900
Ma 100Greater thanMa 200184.834
OpenGreater thanClose189.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Ekadharma International Tbk

PT Ekadharma International Tbk, together with its subsidiaries, engages in manufacturing and sale of self adhesive tapes and related supplementary materials in Indonesia and Malaysia. It operates through Sticking Plaster and Others segments. The company offers lint roller, accessories, industrial tape, packaging products, and cutters; cloth tape/masking tape products; reflective, PVC electrical, and aluminum foil tape; cling wrap, aluminum foil, and zipper bag; kraft tape; OPP tape, including custom, printed, and OPP color tape; and air column bag products. It also engages in general trading business. The company sells its products under the Daimaru, SUPERFIX, and BESTPACK brands. The company was formerly known as PT Ekadharma Widya Grafika and changed its name to PT Ekadharma International Tbk in 2006. The company was founded in 1981 and is headquartered in Tangerang, Indonesia. PT Ekadharma International Tbk is a subsidiary of PT Ekadharma Inti Perkasa.

Fundamental data was last updated by Penke on 2025-09-13 19:06:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Ekadharma earns for each Rp1 of revenue.

  • Above 10% is considered healthy but always compareΒ Ekadharma to theΒ Specialty Chemicals industry mean.
  • A Net Profit Margin of 12.1%Β means thatΒ Rp0.12 for each Rp1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ekadharma International Tbk:

  • The MRQ is 12.1%. The company is making a huge profit. +2
  • The TTM is 12.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.1%TTM12.1%0.0%
TTM12.1%YOY13.9%-1.7%
TTM12.1%5Y13.8%-1.7%
5Y13.8%10Y12.5%+1.3%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ12.1%3.4%+8.7%
TTM12.1%3.3%+8.8%
YOY13.9%3.7%+10.2%
3Y12.8%3.7%+9.1%
5Y13.8%5.4%+8.4%
10Y12.5%5.5%+7.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Ekadharma is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Ekadharma to theΒ Specialty Chemicals industry mean.
  • 5.0% Return on Assets means thatΒ Ekadharma generatedΒ Rp0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ekadharma International Tbk:

  • The MRQ is 5.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 5.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.0%TTM5.0%0.0%
TTM5.0%YOY5.8%-0.8%
TTM5.0%5Y6.9%-1.9%
5Y6.9%10Y8.5%-1.6%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0%0.9%+4.1%
TTM5.0%0.8%+4.2%
YOY5.8%1.0%+4.8%
3Y5.7%1.0%+4.7%
5Y6.9%1.4%+5.5%
10Y8.5%1.5%+7.0%
4.3.1.3. Return on Equity

Shows how efficient Ekadharma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Ekadharma to theΒ Specialty Chemicals industry mean.
  • 5.6% Return on Equity means Ekadharma generated Rp0.06Β for eachΒ Rp1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ekadharma International Tbk:

  • The MRQ is 5.6%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.6%TTM5.6%0.0%
TTM5.6%YOY6.5%-0.9%
TTM5.6%5Y7.9%-2.4%
5Y7.9%10Y10.3%-2.4%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6%1.8%+3.8%
TTM5.6%1.5%+4.1%
YOY6.5%1.9%+4.6%
3Y6.4%1.9%+4.5%
5Y7.9%2.4%+5.5%
10Y10.3%2.6%+7.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Ekadharma International Tbk.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Ekadharma is operatingΒ .

  • Measures how much profit Ekadharma makes for each Rp1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Ekadharma to theΒ Specialty Chemicals industry mean.
  • An Operating Margin of 0.0%Β means the company generated Rp0.00 Β for each Rp1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ekadharma International Tbk:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY14.4%-14.4%
TTM-5Y13.7%-13.7%
5Y13.7%10Y14.8%-1.1%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%-7.2%
TTM-5.3%-5.3%
YOY14.4%5.5%+8.9%
3Y9.6%3.5%+6.1%
5Y13.7%6.4%+7.3%
10Y14.8%6.9%+7.9%
4.3.2.2. Operating Ratio

Measures how efficient Ekadharma is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Specialty Chemicals industry mean).
  • An Operation Ratio of 0.69 means that the operating costs are Rp0.69 for each Rp1 in net sales.

Let's take a look of the Operating Ratio trends of Ekadharma International Tbk:

  • The MRQ is 0.689. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.689. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.689TTM0.6890.000
TTM0.689YOY0.856-0.167
TTM0.6895Y0.801-0.112
5Y0.80110Y0.823-0.022
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6891.497-0.808
TTM0.6891.460-0.771
YOY0.8561.056-0.200
3Y0.8001.214-0.414
5Y0.8011.124-0.323
10Y0.8231.063-0.240
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Ekadharma International Tbk.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ekadharma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Specialty Chemicals industry mean).
  • A Current Ratio of 15.03Β means the company has Rp15.03 in assets for each Rp1 in short-term debts.

Let's take a look of the Current Ratio trends of Ekadharma International Tbk:

  • The MRQ is 15.030. The company is very able to pay all its short-term debts. +2
  • The TTM is 15.030. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ15.030TTM15.0300.000
TTM15.030YOY14.207+0.823
TTM15.0305Y11.371+3.659
5Y11.37110Y8.180+3.192
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ15.0301.738+13.292
TTM15.0301.804+13.226
YOY14.2071.862+12.345
3Y13.6641.883+11.781
5Y11.3711.918+9.453
10Y8.1801.926+6.254
4.4.3.2. Quick Ratio

Measures if Ekadharma is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Ekadharma to theΒ Specialty Chemicals industry mean.
  • A Quick Ratio of 19.02Β means the company can pay off Rp19.02 for each Rp1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ekadharma International Tbk:

  • The MRQ is 19.022. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 19.022. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ19.022TTM19.0220.000
TTM19.022YOY18.043+0.980
TTM19.0225Y11.915+7.107
5Y11.91510Y7.466+4.449
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ19.0220.790+18.232
TTM19.0220.832+18.190
YOY18.0430.945+17.098
3Y15.5360.979+14.557
5Y11.9151.060+10.855
10Y7.4661.136+6.330
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Ekadharma International Tbk.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of EkadharmaΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Ekadharma to Specialty Chemicals industry mean.
  • A Debt to Asset Ratio of 0.10Β means that Ekadharma assets areΒ financed with 10.5% credit (debt) and the remaining percentage (100% - 10.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Ekadharma International Tbk:

  • The MRQ is 0.105. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.105. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.105TTM0.1050.000
TTM0.105YOY0.080+0.025
TTM0.1055Y0.103+0.002
5Y0.10310Y0.136-0.033
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1050.439-0.334
TTM0.1050.433-0.328
YOY0.0800.430-0.350
3Y0.0910.431-0.340
5Y0.1030.423-0.320
10Y0.1360.437-0.301
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Ekadharma is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Ekadharma to theΒ Specialty Chemicals industry mean.
  • A Debt to Equity ratio of 11.7% means that company has Rp0.12 debt for each Rp1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ekadharma International Tbk:

  • The MRQ is 0.117. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.117. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.117TTM0.1170.000
TTM0.117YOY0.089+0.028
TTM0.1175Y0.118-0.001
5Y0.11810Y0.168-0.049
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1170.808-0.691
TTM0.1170.785-0.668
YOY0.0890.784-0.695
3Y0.1020.785-0.683
5Y0.1180.805-0.687
10Y0.1680.858-0.690
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every Rp1 in earnings Ekadharma generates.

  • Above 15 is considered overpriced butΒ always compareΒ Ekadharma to theΒ Specialty Chemicals industry mean.
  • A PE ratio of 0.00 means the investor is paying Rp0.00Β for every Rp1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ekadharma International Tbk:

  • The EOD is 0.001. Based on the earnings, the company is cheap. +2
  • The MRQ is 0.001. Based on the earnings, the company is cheap. +2
  • The TTM is 0.001. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.001MRQ0.0010.000
MRQ0.001TTM0.0010.000
TTM0.001YOY0.0010.000
TTM0.0015Y0.002-0.001
5Y0.00210Y0.0020.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD0.00116.762-16.761
MRQ0.00115.250-15.249
TTM0.00115.746-15.745
YOY0.00117.147-17.146
3Y0.00117.807-17.806
5Y0.00219.773-19.771
10Y0.00224.094-24.092
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ekadharma International Tbk:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.001-0.001
TTM-5Y0.003-0.003
5Y0.00310Y0.004-0.001
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.265-6.265
TTM-1.071-1.071
YOY0.0013.304-3.303
3Y0.0001.640-1.640
5Y0.0032.303-2.300
10Y0.0042.826-2.822
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Ekadharma is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 0.00 means the investor is paying Rp0.00Β for each Rp1 in book value.

Let's take a look of the Price to Book Ratio trends of Ekadharma International Tbk:

  • The EOD is 0.000. Based on the equity, the company is cheap. +2
  • The MRQ is 0.000. Based on the equity, the company is cheap. +2
  • The TTM is 0.000. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.000MRQ0.0000.000
MRQ0.000TTM0.0000.000
TTM0.000YOY0.0000.000
TTM0.0005Y0.0000.000
5Y0.00010Y0.0000.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD0.0001.735-1.735
MRQ0.0001.587-1.587
TTM0.0001.602-1.602
YOY0.0001.793-1.793
3Y0.0001.841-1.841
5Y0.0002.259-2.259
10Y0.0002.611-2.611
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,294,783,335
Total Liabilities135,708,512
Total Stockholder Equity1,159,074,823
 As reported
Total Liabilities 135,708,512
Total Stockholder Equity+ 1,159,074,823
Total Assets = 1,294,783,335

Assets

Total Assets1,294,783,335
Total Current Assets754,223,782
Long-term Assets-
Total Current Assets
Cash And Cash Equivalents 71,757,170
Short-term Investments 396,243,809
Net Receivables 72,254,456
Inventory 187,241,702
Other Current Assets 828,158
Total Current Assets  (as reported)754,223,782
Total Current Assets  (calculated)728,325,296
+/- 25,898,486
Long-term Assets
Property Plant Equipment 483,014,927
Intangible Assets 78,106
Long-term Assets  (as reported)0
Long-term Assets  (calculated)483,093,033
+/- 483,093,033

Liabilities & Shareholders' Equity

Total Current Liabilities50,181,225
Long-term Liabilities-
Total Stockholder Equity1,159,074,823
Total Current Liabilities
Short-term Debt 9,711,876
Total Current Liabilities  (as reported)50,181,225
Total Current Liabilities  (calculated)9,711,876
+/- 40,469,349
Long-term Liabilities
Long term Debt Total 16,246,991
Capital Lease Obligations Min Short Term Debt-9,711,876
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)6,535,115
+/- 6,535,115
Total Stockholder Equity
Common Stock34,938,750
Retained Earnings 774,271,991
Capital Surplus 138,490
Other Stockholders Equity 52,663,572
Total Stockholder Equity (as reported)1,159,074,823
Total Stockholder Equity (calculated)862,012,803
+/- 297,062,019
Other
Cash And Equivalents18,065,501
Cash and Short Term Investments 486,066,480
Common Stock Shares Outstanding 3,493,875
Liabilities and Stockholders Equity 1,294,783,335



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
58,399,000
59,709,706
58,490,885
60,824,949
63,086,297
75,163,641
74,646,683
84,926,215
140,763,762
165,122,503
204,470,483
237,592,308
273,893,467
343,601,504
411,726,183
389,691,596
702,508,631
796,767,646
853,267,454
968,234,350
1,088,923,588
1,165,564,745
1,221,291,886
1,247,265,695
1,294,783,335
1,294,783,3351,247,265,6951,221,291,8861,165,564,7451,088,923,588968,234,350853,267,454796,767,646702,508,631389,691,596411,726,183343,601,504273,893,467237,592,308204,470,483165,122,503140,763,76284,926,21574,646,68375,163,64163,086,29760,824,94958,490,88559,709,70658,399,000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
180,370,886
229,041,255
296,439,332
284,055,203
337,644,084
413,617,087
461,472,622
486,522,278
552,493,858
643,773,422
669,455,043
715,050,204
754,223,782
754,223,782715,050,204669,455,043643,773,422552,493,858486,522,278461,472,622413,617,087337,644,084284,055,203296,439,332229,041,255180,370,886000000000000
       Cash And Cash Equivalents 
3,447,000
3,953,356
4,800,716
3,525,908
2,069,312
1,061,166
2,232,927
6,295,823
4,221,793
0
1,698,999
7,056,319
6,427,675
9,840,519
13,222,554
49,519,816
94,849,703
112,224,190
109,698,978
161,870,307
348,026,903
360,662,680
392,549,234
126,639,835
71,757,170
71,757,170126,639,835392,549,234360,662,680348,026,903161,870,307109,698,978112,224,19094,849,70349,519,81613,222,5549,840,5196,427,6757,056,3191,698,99904,221,7936,295,8232,232,9271,061,1662,069,3123,525,9084,800,7163,953,3563,447,000
       Short-term Investments 
12,933,000
23,657,679
20,000,000
17,000,000
19,655,000
19,767,790
14,072,717
11,187,111
4,282,260
0
26,680,813
29,004,021
24,168,486
20,819,148
26,295,675
20,732,550
20,139,711
18,454,135
13,154,935
31,124,931
21,103,843
24,219,915
37,851,644
356,059,645
396,243,809
396,243,809356,059,64537,851,64424,219,91521,103,84331,124,93113,154,93518,454,13520,139,71120,732,55026,295,67520,819,14824,168,48629,004,02126,680,81304,282,26011,187,11114,072,71719,767,79019,655,00017,000,00020,000,00023,657,67912,933,000
       Net Receivables 
12,658,000
9,840,551
8,155,101
9,856,130
9,007,771
13,080,118
15,938,609
22,574,075
21,925,088
24,710,046
31,040,409
41,747,153
49,624,880
62,545,480
73,793,334
70,048,850
81,737,871
91,479,658
104,243,059
103,962,867
88,763,735
84,009,934
75,145,828
69,349,734
72,254,456
72,254,45669,349,73475,145,82884,009,93488,763,735103,962,867104,243,05991,479,65881,737,87170,048,85073,793,33462,545,48049,624,88041,747,15331,040,40924,710,04621,925,08822,574,07515,938,60913,080,1189,007,7719,856,1308,155,1019,840,55112,658,000
       Other Current Assets 
646,000
847,354
577,832
3,022,618
991,915
3,583,457
3,816,651
3,399,072
72,392,567
6,004,405
7,396,975
4,911,831
14,036,509
17,091,108
13,771,917
19,458,894
15,139,841
12,502,526
20,747,924
4,793,501
8,190,026
6,591,901
1,436,645
5,515,858
828,158
828,1585,515,8581,436,6456,591,9018,190,0264,793,50120,747,92412,502,52615,139,84119,458,89413,771,91717,091,10814,036,5094,911,8317,396,9756,004,40572,392,5673,399,0723,816,6513,583,457991,9153,022,618577,832847,354646,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
89,817,393
101,914,040
108,479,816
99,729,983
358,117,888
368,193,790
376,186,341
481,712,071
536,429,730
521,791,323
551,836,843
532,215,490
0
0532,215,490551,836,843521,791,323536,429,730481,712,071376,186,341368,193,790358,117,88899,729,983108,479,816101,914,04089,817,393000000000000
       Property Plant Equipment 
11,763,000
11,616,853
12,495,571
12,816,018
11,735,999
11,925,958
12,202,462
12,592,552
12,324,770
66,641,467
67,542,387
74,431,794
85,360,513
97,514,665
105,345,566
96,595,733
354,771,515
364,850,962
371,559,780
465,475,205
477,023,220
465,809,351
487,602,808
481,072,905
483,014,927
483,014,927481,072,905487,602,808465,809,351477,023,220465,475,205371,559,780364,850,962354,771,51596,595,733105,345,56697,514,66585,360,51374,431,79467,542,38766,641,46712,324,77012,592,55212,202,46211,925,95811,735,99912,816,01812,495,57111,616,85311,763,000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,134,250
3,346,372
3,342,828
3,409,547
0
0
0
0
0
0
0000003,409,5473,342,8283,346,3723,134,250000000000000000
       Intangible Assets 
0
0
0
0
0
0
1,776,173
2,049,242
1,975,892
1,495,147
1,437,642
1,380,136
1,322,630
1,265,125
0
0
0
0
1,217,014
912,761
608,507
511,213
234,887
131,928
78,106
78,106131,928234,887511,213608,507912,7611,217,01400001,265,1251,322,6301,380,1361,437,6421,495,1471,975,8922,049,2421,776,173000000
       Other Assets 
0
0
0
1,145,244
785,009
1,466,480
1,259,910
1,472,142
1,031,873
2,931,420
9,538,473
2,598,582
3,705,188
12,646,209
6,807,035
5,906,409
6,746,659
14,956,769
15,608,492
21,743,563
6,754,172
61,126,366
321,345
0
1,818,871
1,818,8710321,34561,126,3666,754,17221,743,56315,608,49214,956,7696,746,6595,906,4096,807,03512,646,2093,705,1882,598,5829,538,4732,931,4201,031,8731,472,1421,259,9101,466,480785,0091,145,244000
> Total Liabilities 
14,094,000
12,836,527
9,782,768
11,037,349
9,553,560
20,358,219
16,710,061
24,030,111
60,864,566
76,211,305
79,271,063
89,946,780
81,915,660
105,893,943
143,820,129
97,730,179
110,503,823
133,949,921
128,684,953
115,690,799
136,561,030
135,165,299
108,448,241
99,504,676
135,708,512
135,708,51299,504,676108,448,241135,165,299136,561,030115,690,799128,684,953133,949,921110,503,82397,730,179143,820,129105,893,94381,915,66089,946,78079,271,06376,211,30560,864,56624,030,11116,710,06120,358,2199,553,56011,037,3499,782,76812,836,52714,094,000
   > Total Current Liabilities 
13,773,000
12,375,602
9,380,258
10,396,337
8,941,822
17,139,046
14,369,349
21,166,043
47,030,482
64,475,926
69,499,302
81,808,619
74,814,330
98,355,432
127,248,838
79,594,447
69,110,450
91,524,722
91,381,684
70,337,530
68,166,758
82,981,082
56,947,976
50,331,126
50,181,225
50,181,22550,331,12656,947,97682,981,08268,166,75870,337,53091,381,68491,524,72269,110,45079,594,447127,248,83898,355,43274,814,33081,808,61969,499,30264,475,92647,030,48221,166,04314,369,34917,139,0468,941,82210,396,3379,380,25812,375,60213,773,000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,253,169
14,411,744
22,786,838
22,363,466
20,224,825
15,488,192
31,138,719
13,471,667
5,824,890
9,711,876
9,711,8765,824,89013,471,66731,138,71915,488,19220,224,82522,363,46622,786,83814,411,74431,253,169000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131,384
5,975,904
6,600,212
6,902,236
0
0
0
0
0
0
0000006,902,2366,600,2125,975,904131,384000000000000000
       Accounts payable 
11,768,000
6,677,140
7,041,392
7,487,468
6,748,203
15,168,412
10,338,363
15,907,179
9,446,279
12,155,236
16,463,323
23,977,984
17,522,610
23,731,578
37,522,678
30,906,095
23,105,498
47,963,452
46,438,734
29,416,419
25,670,003
33,568,630
31,221,962
29,902,280
0
029,902,28031,221,96233,568,63025,670,00329,416,41946,438,73447,963,45223,105,49830,906,09537,522,67823,731,57817,522,61023,977,98416,463,32312,155,2369,446,27915,907,17910,338,36315,168,4126,748,2037,487,4687,041,3926,677,14011,768,000
       Other Current Liabilities 
2,005,000
2,360,062
2,338,866
2,908,869
2,193,619
1,970,634
4,030,986
3,641,611
4,243,943
8,748,844
6,944,631
8,422,426
57,291,720
74,623,854
89,726,160
48,688,352
46,004,953
43,561,270
44,942,949
20,605,481
12,469,720
10,842,511
9,177,197
9,850,584
0
09,850,5849,177,19710,842,51112,469,72020,605,48144,942,94943,561,27046,004,95348,688,35289,726,16074,623,85457,291,7208,422,4266,944,6318,748,8444,243,9433,641,6114,030,9861,970,6342,193,6192,908,8692,338,8662,360,0622,005,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
1,399,650
314,201
369,441
232,481
20,723,190
16,469,122
10,346,517
45,353,269
68,394,272
52,184,217
51,500,266
49,173,550
0
049,173,55051,500,26652,184,21768,394,27245,353,26910,346,51716,469,12220,723,190232,481369,441314,2011,399,650000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
232,481
20,723,190
16,469,122
10,346,517
8,108,720
22,163,416
19,451,387
17,882,250
15,828,671
16,246,991
16,246,99115,828,67117,882,25019,451,38722,163,4168,108,72010,346,51716,469,12220,723,190232,481000000000000000
       Other Liabilities 
0
174,549
263,562
641,012
611,738
3,219,173
2,340,712
2,864,069
2,599,943
3,067,976
2,953,991
4,108,941
5,701,681
7,224,310
9,144,279
17,903,251
20,670,182
25,956,077
26,956,753
37,244,550
39,287,089
32,732,830
0
0
0
00032,732,83039,287,08937,244,55026,956,75325,956,07720,670,18217,903,2519,144,2797,224,3105,701,6814,108,9412,953,9913,067,9762,599,9432,864,0692,340,7123,219,173611,738641,012263,562174,5490
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
300,466
284,861
0
0
0
0
0
0
0
0
00000000284,861300,466000000000000000
> Total Stockholder Equity
43,879,000
46,523,169
48,570,194
49,787,600
53,532,737
54,805,422
57,875,158
60,840,715
59,020,079
69,524,864
106,522,066
129,989,457
174,094,293
219,226,705
248,712,054
272,848,894
570,342,910
640,315,220
700,390,074
825,692,019
923,084,432
998,239,584
1,080,896,665
1,114,234,230
1,159,074,823
1,159,074,8231,114,234,2301,080,896,665998,239,584923,084,432825,692,019700,390,074640,315,220570,342,910272,848,894248,712,054219,226,705174,094,293129,989,457106,522,06669,524,86459,020,07960,840,71557,875,15854,805,42253,532,73749,787,60048,570,19446,523,16943,879,000
   Common Stock
22,361,000
22,360,800
22,360,800
22,360,800
22,360,800
22,360,800
27,951,000
27,951,000
27,951,000
27,951,000
27,951,000
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,750
34,938,75034,938,75034,938,75034,938,75034,938,75034,938,75034,938,75034,938,75034,938,75034,938,75034,938,75034,938,75034,938,75034,938,75027,951,00027,951,00027,951,00027,951,00027,951,00022,360,80022,360,80022,360,80022,360,80022,360,80022,361,000
   Retained Earnings 
17,453,000
20,075,167
22,296,904
24,213,700
26,449,162
27,901,943
22,289,751
24,845,759
28,334,089
43,100,367
65,908,472
87,814,987
118,893,866
152,156,977
180,617,759
222,385,991
312,794,243
385,899,076
450,509,716
496,702,739
568,135,533
643,398,070
686,955,441
729,004,123
774,271,991
774,271,991729,004,123686,955,441643,398,070568,135,533496,702,739450,509,716385,899,076312,794,243222,385,991180,617,759152,156,977118,893,86687,814,98765,908,47243,100,36728,334,08924,845,75922,289,75127,901,94326,449,16224,213,70022,296,90420,075,16717,453,000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
138,490
138,490
138,490
138,490
138,490
138,490
138,490
138,490
138,490
138,490
138,490138,490138,490138,490138,490138,490138,490138,490138,490138,490000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
20,261,677
32,130,978
33,155,546
15,524,152
222,609,917
219,477,394
214,941,608
138,490
138,490
138,490
138,490
138,490
52,663,572
52,663,572138,490138,490138,490138,490138,490214,941,608219,477,394222,609,91715,524,15233,155,54632,130,97820,261,677000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue530,431,613
Cost of Revenue-365,504,856
Gross Profit164,926,758164,926,758
 
Operating Income (+$)
Gross Profit164,926,758
Operating Expense--
Operating Income65,554,778164,926,758
 
Operating Expense (+$)
Research Development-
Selling General Administrative94,453,516
Selling And Marketing Expenses-
Operating Expense-94,453,516
 
Net Interest Income (+$)
Interest Income16,103,797
Interest Expense-951,377
Other Finance Cost-15,152,420
Net Interest Income-
 
Pretax Income (+$)
Operating Income65,554,778
Net Interest Income-
Other Non-Operating Income Expenses-
Income Before Tax (EBT)81,618,65365,554,778
EBIT - interestExpense = -951,377
64,435,010
65,386,387
Interest Expense951,377
Earnings Before Interest and Taxes (EBIT)-82,570,029
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax81,618,653
Tax Provision-17,062,756
Net Income From Continuing Ops-64,555,896
Net Income64,435,010
Net Income Applicable To Common Shares64,435,010
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-0
 

Technical Analysis of Ekadharma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ekadharma. The general trend of Ekadharma is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ekadharma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Ekadharma Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ekadharma International Tbk.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 192.00 < 192.00 < 192.00.

The bearish price targets are: 182.00 > 182.00 > 180.00.

Know someone who trades $EKAD? Share this with them.πŸ‘‡

Ekadharma International Tbk Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ekadharma International Tbk. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ekadharma International Tbk Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ekadharma International Tbk. The current macd is 0.77794046.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ekadharma price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Ekadharma. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Ekadharma price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ekadharma International Tbk Daily Moving Average Convergence/Divergence (MACD) ChartEkadharma International Tbk Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ekadharma International Tbk. The current adx is 19.00.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Ekadharma shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Ekadharma International Tbk Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ekadharma International Tbk. The current sar is 181.37.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Ekadharma International Tbk Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ekadharma International Tbk. The current rsi is 52.11. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Ekadharma International Tbk Daily Relative Strength Index (RSI) ChartEkadharma International Tbk Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ekadharma International Tbk. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ekadharma price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ekadharma International Tbk Daily Stochastic Oscillator ChartEkadharma International Tbk Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ekadharma International Tbk. The current cci is -5.40540541.

Ekadharma International Tbk Daily Commodity Channel Index (CCI) ChartEkadharma International Tbk Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ekadharma International Tbk. The current cmo is 0.79546462.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Ekadharma International Tbk Daily Chande Momentum Oscillator (CMO) ChartEkadharma International Tbk Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ekadharma International Tbk. The current willr is -33.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ekadharma is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Ekadharma International Tbk Daily Williams %R ChartEkadharma International Tbk Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Ekadharma International Tbk.

Ekadharma International Tbk Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ekadharma International Tbk. The current atr is 3.43238937.

Ekadharma International Tbk Daily Average True Range (ATR) ChartEkadharma International Tbk Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ekadharma International Tbk. The current obv is 2,882,300.

Ekadharma International Tbk Daily On-Balance Volume (OBV) ChartEkadharma International Tbk Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ekadharma International Tbk. The current mfi is 27.22.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ekadharma International Tbk Daily Money Flow Index (MFI) ChartEkadharma International Tbk Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ekadharma International Tbk.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-04-25WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-04-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-05-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-06-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-24MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-08-25MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Ekadharma International Tbk Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ekadharma International Tbk based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.106
Ma 20Greater thanMa 50188.300
Ma 50Greater thanMa 100185.900
Ma 100Greater thanMa 200184.834
OpenGreater thanClose189.000
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ekadharma with someone you think should read this too:
  • Are you bullish or bearish on Ekadharma? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ekadharma? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ekadharma International Tbk

I send you an email if I find something interesting about Ekadharma International Tbk.


Comments

How you think about this?

Leave a comment

Stay informed about Ekadharma International Tbk.

Receive notifications about Ekadharma International Tbk in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.